These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 28402834)

  • 1. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.
    Kantanen AM; Sairanen J; Kälviäinen R
    Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and mortality of super-refractory status epilepticus in adults.
    Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
    Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.
    Kantanen AM; Kälviäinen R; Parviainen I; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Reinikainen M
    Crit Care; 2017 Mar; 21(1):71. PubMed ID: 28330483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with occurrence and outcome of super-refractory status epilepticus.
    Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
    Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
    Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
    Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study.
    Sutter R; Marsch S; Fuhr P; Rüegg S
    Epilepsia; 2013 Mar; 54(3):502-11. PubMed ID: 23294049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.
    Strzelczyk A; Ansorge S; Hapfelmeier J; Bonthapally V; Erder MH; Rosenow F
    Epilepsia; 2017 Sep; 58(9):1533-1541. PubMed ID: 28681418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit.
    Vooturi S; Jayalakshmi S; Sahu S; Mohandas S
    Clin Neurol Neurosurg; 2014 Nov; 126():7-10. PubMed ID: 25194304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting mortality of refractory status epilepticus.
    Tatlidil I; Ture HS; Akhan G
    Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status epilepticus: Refractory and super-refractory.
    Dubey D; Kalita J; Misra UK
    Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric refractory and super-refractory status epilepticus.
    Vasquez A; Farias-Moeller R; Tatum W
    Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
    Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
    J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.